A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (Q43199044)
Jump to navigation
Jump to search
scientific article published on 7 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer |
scientific article published on 7 January 2010 |
Statements
1 reference
A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (English)
1 reference
Jina Yun
1 reference
Jeeyun Lee
1 reference
Se Hoon Park
1 reference
Joon Oh Park
1 reference
Young Suk Park
1 reference
Ho Yeong Lim
1 reference
Won Ki Kang
1 reference
7 January 2010
1 reference
1 reference
Identifiers
1 reference